Skip to main content
Fig. 1 | BMC Medical Genomics

Fig. 1

From: Clinicopathological value of the upregulation of cyclin-dependent kinases regulatory subunit 2 in osteosarcoma

Fig. 1

Hematoxylin–eosin (HE) staining and Immunohistochemistry (IHC) staining of CKS2 in osteosarcoma (OS) and non-tumor tissues. A HE staining of CKS2 in non-tumor tissues (100×) and OS tissues (100×, 200×, 400×). B Plots showing the staining intensity prospectively scored by pathologists. C Negative IHC staining of CKS2 in non-tumor tissues (200×,400×); Moderate positive IHC staining of CKS2 in OS tissues (200×,400×); Strong positive IHC staining of CKS2 in OS tissues (200×,400×). D Box-plot of IHC staining displayed expression analysis of CKS2. E The receiver operator characteristic (ROC) curve of IHC staining displayed expression analysis of CKS2

Back to article page

BMC Medical Genomics

ISSN: 1755-8794

Contact us